TABLE 2.

Patient characteristics II.

Characteristics	NLR		p‐value	PLR		p‐value	SII		p‐value
	Low	High		Low	High		Low	High
Gender			0.018			0.013			0.16
Male	89	111		113	87		93	107
Female	126	99		100	125		120	105
Age (years)			0.16			0.961			0.029
≤	100	112		106	106		95	117
>	115	98		107	106		118	95
WHO type			0.783			0.286			0.576
A	21	19		21	19		21	19
AB	75	78		69	84		72	81
B (B1, B2, B3)	119	113		123	109		120	112
Tumor size			0.69			0.812			0.155
≤	129	122		127	124		133	118
>	86	88		86	88		80	94
Myasthenia			0.929			0.037			0.376
Yes	25	26		32	19		28	23
No	190	184		181	193		185	189
Extended resection			0.540			0.2			0.845
Yes	15	18		13	20		16	17
No	200	192		200	192		197	195
Masaoka‐Koga stage			0.145			0.437			0.44
I	137	123		131	129		132	128
II	57	62		61	58		59	60
III	19	18		17	20		19	18
IV	2	7		4	5		3	6

Note: Bold values represent statistically significant results.

Abbreviations: NLR neutrophil‐to‐lymphocyte ratio; PLR, platelet‐to‐lymphocyte ratio; SII, systemic immune‐inflammation index; WHO World Health Organization.